title: L1, a novel target of beta-catenin signaling, transforms cells and is expressed at the invasive front of colon cancers.
abstract: Aberrant beta-catenin-TCF target gene activation plays a key role in colorectal cancer, both in the initiation stage and during invasion and metastasis. We identified the neuronal cell adhesion molecule L1, as a target gene of beta-catenin-TCF signaling in colorectal cancer cells. L1 expression was high in sparse cultures and coregulated with ADAM10, a metalloprotease involved in cleaving and shedding L1's extracellular domain. L1 expression conferred increased cell motility, growth in low serum, transformation and tumorigenesis, whereas its suppression in colon cancer cells decreased motility. L1 was exclusively localized in the invasive front of human colorectal tumors together with ADAM10. The transmembrane localization and shedding of L1 by metalloproteases could be useful for detection and as target for colon cancer therapy.
authors.affiliation: Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, 76100, Israel.
authors.forename: Nancy
authors.initials: N
authors.lastname: Gavert
authors.forename: Maralice
authors.initials: M
authors.lastname: Conacci-Sorrell
authors.forename: Daniela
authors.initials: D
authors.lastname: Gast
authors.forename: Annette
authors.initials: A
authors.lastname: Schneider
authors.forename: Peter
authors.initials: P
authors.lastname: Altevogt
authors.forename: Thomas
authors.initials: T
authors.lastname: Brabletz
authors.forename: Avri
authors.initials: A
authors.lastname: Ben-Ze'ev
mesh_terms: D051722:ADAM Proteins; D000072197:ADAM10 Protein; D053829:Amyloid Precursor Protein Secretases; D000818:Animals; D002465:Cell Movement / Q000235:genetics / Q000502:physiology*; D049109:Cell Proliferation; D002471:Cell Transformation, Neoplastic / Q000235:genetics / Q000378:metabolism*; D003110:Colonic Neoplasms / Q000235:genetics / Q000378:metabolism*; D003598:Cytoskeletal Proteins / Q000378:metabolism*; D006801:Humans; D007150:Immunohistochemistry; D008565:Membrane Proteins; D008666:Metalloendopeptidases; D051379:Mice; D041681:NIH 3T3 Cells; D039842:Neural Cell Adhesion Molecule L1 / Q000235:genetics / Q000378:metabolism*; D011401:Promoter Regions, Genetic / Q000235:genetics; D034741:RNA, Small Interfering / Q000378:metabolism; D015398:Signal Transduction / Q000235:genetics / Q000502:physiology; D015534:Trans-Activators / Q000378:metabolism*; D014407:Tumor Cells, Cultured; D051176:beta Catenin
chemical_list: C495270:CTNNB1 protein, human; C495267:CTNNB1 protein, mouse; D003598:Cytoskeletal Proteins; D008565:Membrane Proteins; D039842:Neural Cell Adhesion Molecule L1; D034741:RNA, Small Interfering; D015534:Trans-Activators; D051176:beta Catenin; D053829:Amyloid Precursor Protein Secretases; D051722:ADAM Proteins; D008666:Metalloendopeptidases; D000072197:ADAM10 Protein; C491236:ADAM10 protein, human
references.citation: Clin Exp Metastasis. 1993 Sep;11(5):419-29
references.pmid: 8375117
references.citation: Genomics. 1991 Oct;11(2):416-23
references.pmid: 1769655
references.citation: Science. 1997 Mar 21;275(5307):1787-90
references.pmid: 9065402
references.citation: J Cell Biol. 1997 Sep 22;138(6):1343-54
references.pmid: 9298989
references.citation: J Biol Chem. 1999 Dec 31;274(53):37965-73
references.pmid: 10608864
references.citation: Cancer Res. 2000 Mar 15;60(6):1552-6
references.pmid: 10749122
references.citation: Hum Mol Genet. 2000 Apr 12;9(6):879-86
references.pmid: 10767310
references.citation: Genes Dev. 2000 Aug 1;14(15):1837-51
references.pmid: 10921899
references.citation: Cell. 2000 Oct 13;103(2):311-20
references.pmid: 11057903
references.citation: J Surg Oncol. 2001 May;77(1):49-54
references.pmid: 11344483
references.citation: Cancer Res. 2001 Sep 1;61(17):6345-9
references.pmid: 11522623
references.citation: Proc Natl Acad Sci U S A. 2001 Aug 28;98(18):10356-61
references.pmid: 11526241
references.citation: J Cell Biol. 2001 Nov 12;155(4):661-73
references.pmid: 11706054
references.citation: Cancer Res. 2001 Nov 15;61(22):8089-93
references.pmid: 11719433
references.citation: Trends Mol Med. 2001 Dec;7(12):535-7
references.pmid: 11733201
references.citation: Hum Mol Genet. 2002 Jan 1;11(1):1-12
references.pmid: 11772994
references.citation: Cancer Res. 1998 Apr 1;58(7):1344-7
references.pmid: 9537226
references.citation: J Cell Biol. 1998 Jun 15;141(6):1433-48
references.pmid: 9628899
references.citation: Science. 1998 Sep 4;281(5382):1509-12
references.pmid: 9727977
references.citation: Mol Cell Neurosci. 1998 Sep;12(1-2):48-55
references.pmid: 9770339
references.citation: Curr Opin Cell Biol. 1998 Oct;10(5):629-39
references.pmid: 9818174
references.citation: Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15339-44
references.pmid: 9860970
references.citation: J Cell Biol. 1998 Dec 28;143(7):2067-79
references.pmid: 9864376
references.citation: Oncogene. 1999 Jan 21;18(3):813-22
references.pmid: 9989833
references.citation: Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1603-8
references.pmid: 9990071
references.citation: Am J Pathol. 1999 Feb;154(2):515-23
references.pmid: 10027409
references.citation: Proc Natl Acad Sci U S A. 1999 Mar 2;96(5):2420-5
references.pmid: 10051657
references.citation: Nature. 1999 Apr 1;398(6726):422-6
references.pmid: 10201372
references.citation: Proc Natl Acad Sci U S A. 1999 May 11;96(10):5522-7
references.pmid: 10318916
references.citation: Oncogene. 1999 May 6;18(18):2883-91
references.pmid: 10362259
references.citation: Mol Cell Biol. 1999 Aug;19(8):5576-87
references.pmid: 10409747
references.citation: Am J Pathol. 1999 Oct;155(4):1033-8
references.pmid: 10514384
references.citation: Am J Med Genet. 2002 Feb 15;108(1):51-6
references.pmid: 11857550
references.citation: J Clin Invest. 2002 Apr;109(8):987-91
references.pmid: 11956233
references.citation: Eur J Cancer. 2002 Sep;38(13):1708-16
references.pmid: 12175686
references.citation: Genes Dev. 2002 Aug 15;16(16):2058-72
references.pmid: 12183361
references.citation: Oncogene. 2002 Aug 29;21(38):5861-7
references.pmid: 12185585
references.citation: Cell. 2002 Oct 18;111(2):241-50
references.pmid: 12408868
references.citation: Cell. 2002 Oct 18;111(2):251-63
references.pmid: 12408869
references.citation: Oncogene. 2002 Nov 14;21(52):7981-90
references.pmid: 12439748
references.citation: Nature. 2002 Nov 21;420(6913):274-5, 277
references.pmid: 12447423
references.citation: FASEB J. 2003 Feb;17(2):292-4
references.pmid: 12475894
references.citation: EMBO Rep. 2003 Jun;4(6):609-15
references.pmid: 12776180
references.citation: Cancer Cell. 2003 Jul;4(1):41-53
references.pmid: 12892712
references.citation: Lancet. 2003 Sep 13;362(9387):869-75
references.pmid: 13678974
references.citation: Int J Cancer. 2004 Jan 10;108(2):321-6
references.pmid: 14639622
references.citation: J Cell Biol. 2003 Nov 24;163(4):847-57
references.pmid: 14623871
references.citation: J Biol Chem. 2004 Jul 9;279(28):28880-8
references.pmid: 15128735
references.citation: EMBO J. 1987 Sep;6(9):2581-6
references.pmid: 3315649
references.citation: Cell. 1994 Jun 17;77(6):841-52
references.pmid: 7911739